Key Details
Price
$3.29Annual EPS
-$2.25Annual ROE
-46.62%Beta
0.58Events Calendar
Next earnings date:
May 07, 2025Recent quarterly earnings:
Nov 14, 2024Recent annual earnings:
Mar 22, 2023Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
May 16, 2023Analyst ratings
Recent major analysts updates
20 Oct '21 Truist Securities
Buy24 Sept '21 Cantor Fitzgerald
OverweightScreeners with CYCN included
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Cyclerion Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Cyclerion's sGC Stimulator Portfolio Generates Revenues to Enable Company Growth
CYCN
globenewswire.com17 December 2024
CAMBRIDGE, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), today announced an update on its progress in catalyzing the Company's next stage of growth.
Regina Graul, Ph.D., Promoted to Chief Executive Officer
CYCN
globenewswire.com07 August 2024
CAMBRIDGE, Mass., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), today announced that Regina Graul, Ph.D.
FAQ
- What is the primary business of Cyclerion Therapeutics?
- What is the ticker symbol for Cyclerion Therapeutics?
- Does Cyclerion Therapeutics pay dividends?
- What sector is Cyclerion Therapeutics in?
- What industry is Cyclerion Therapeutics in?
- What country is Cyclerion Therapeutics based in?
- When did Cyclerion Therapeutics go public?
- Is Cyclerion Therapeutics in the S&P 500?
- Is Cyclerion Therapeutics in the NASDAQ 100?
- Is Cyclerion Therapeutics in the Dow Jones?
- When was Cyclerion Therapeutics's last earnings report?
- When does Cyclerion Therapeutics report earnings?
- Should I buy Cyclerion Therapeutics stock now?
What is the primary business of Cyclerion Therapeutics?
Cyclerion Therapeutics is a biotechnology company focused on developing innovative treatments for neurological diseases. They specialize in creating drugs that target the central nervous system, aiming to improve the lives of patients with conditions like Alzheimer's and other cognitive disorders.
What is the ticker symbol for Cyclerion Therapeutics?
The ticker symbol for Cyclerion Therapeutics is NASDAQ:CYCN
Does Cyclerion Therapeutics pay dividends?
No, Cyclerion Therapeutics does not pay dividends
What sector is Cyclerion Therapeutics in?
Cyclerion Therapeutics is in the Healthcare sector
What industry is Cyclerion Therapeutics in?
Cyclerion Therapeutics is in the Biotechnology industry
What country is Cyclerion Therapeutics based in?
Cyclerion Therapeutics is headquartered in United States
When did Cyclerion Therapeutics go public?
Cyclerion Therapeutics's initial public offering (IPO) was on 18 March 2019
Is Cyclerion Therapeutics in the S&P 500?
No, Cyclerion Therapeutics is not included in the S&P 500 index
Is Cyclerion Therapeutics in the NASDAQ 100?
No, Cyclerion Therapeutics is not included in the NASDAQ 100 index
Is Cyclerion Therapeutics in the Dow Jones?
No, Cyclerion Therapeutics is not included in the Dow Jones index
When was Cyclerion Therapeutics's last earnings report?
Cyclerion Therapeutics's most recent earnings report was on 14 November 2024
When does Cyclerion Therapeutics report earnings?
The next expected earnings date for Cyclerion Therapeutics is 7 May 2025
Should I buy Cyclerion Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions